Cargando…
Metabolic Plasticity in Chemotherapy Resistance
Resistance of cancer cells to chemotherapy is the first cause of cancer-associated death. Thus, new strategies to deal with the evasion of drug response and to improve clinical outcomes are needed. Genetic and epigenetic mechanisms associated with uncontrolled cell growth result in metabolism reprog...
Autores principales: | Desbats, Maria Andrea, Giacomini, Isabella, Prayer-Galetti, Tommaso, Montopoli, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068907/ https://www.ncbi.nlm.nih.gov/pubmed/32211323 http://dx.doi.org/10.3389/fonc.2020.00281 |
Ejemplares similares
-
Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy
por: Giacomini, Isabella, et al.
Publicado: (2021) -
Editorial: Metabolism Meets Function: The Multifaced Role of Metabolism in Cancer
por: Giacomini, Isabella, et al.
Publicado: (2022) -
The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance
por: Giacomini, Isabella, et al.
Publicado: (2020) -
Urological Care and COVID-19: Looking Forward
por: Prayer-Galetti, Tommaso, et al.
Publicado: (2020) -
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy
por: Montopoli, M., et al.
Publicado: (2021)